P11511 (CP19A_HUMAN) Homo sapiens (Human)

Aromatase UniProtKBInterProSTRINGInteractive Modelling

503 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Homo sapiens: A0A024R5S8; Pan paniscus: A0A2R9A604

Sequence Features

 437Iron (heme axial ligand).
 39W -> R (in dbSNP:rs2236722). VAR_023428 dbSNP
 192R -> H (in AROD; strongly reduced aromatase activity; 81% reduction of androstenedione metabolism compared to wild-type; dbSNP:rs765057534). VAR_072784 dbSNP
 201T -> M (in dbSNP:rs28757184). VAR_023429 dbSNP
 264R -> C (1.6 fold decrease in affinity for androstenedione substrate; slightly affects PKA-mediated reduction in catalytic activity as measured in vitro by estrone synthesis from androstenedione (49% decrease compared with 36% for the wild-type protein); no effect on PKG/ PRKG1-mediated reduction in catalytic activity in vitro; dbSNP:rs700519). VAR_018406 dbSNP
 264R -> H (2.5 fold decrease in affinity for androstenedione substrate; slightly affects PKA-mediated reduction in catalytic activity as measured by estrone synthesis from androstenedione in vitro (28% decrease compared with 36% for the wild-type protein) and PKG/PRKG1-mediated reduction in catalytic activity in vitro (15% decrease compared with 30% for the wild-type protein); dbSNP:rs2304462). VAR_077526 dbSNP
 314S -> P (found in deaf patients; unknown pathological significance). VAR_079486
 365R -> Q (in AROD; 0.4% of wild-type activity; dbSNP:rs80051519). VAR_016962 dbSNP
 375R -> C (in AROD; dbSNP:rs121434536). VAR_016963 dbSNP
 375R -> L (in dbSNP:rs762631156). VAR_054152 dbSNP
 435R -> C (in AROD; 1.1% of wild-type activity; dbSNP:rs121434534). VAR_016964 dbSNP
 437C -> Y (in AROD; complete loss of activity; dbSNP:rs78310315). VAR_016965 dbSNP
 50-484Cytochrome P450
IPR001128PF00067

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
'HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLY...monomer HEM;PO4;1PE;ASD;5jkv45-496
Human placental aromatase cytochrome P450 (CYP19A1) refined at 2.75 angstrommonomer HEM;PO4;ASD;3s7945-496
Crystal structure of human placental aromatase cytochrome P450 in complex with androstenedionemonomer HEM;PO4;ASD;3eqm45-496
HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONEmonomer HEM;TES;5jkw45-496
HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2monomer HEM;ASD;5jl645-496
HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3monomer HEM;ASD;5jl745-496
HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4monomer HEM;ASD;5jl945-496
Crystal structure of human placental aromatase complexed with breast cancer drug exemestanemonomer HEM;EXM;3s7s45-496
Structure of Recombinant Human Cytochrome P450 Aromatasemonomer HEM;PO4;ASD;4kq845-496
Structure of human placental aromatase complexed with designed inhibitor HDDG029 (compound 4)monomer HEM;G29;4gl545-496
Structure of human placental aromatase complexed with designed inhibitor HDDG046 (compound 5)monomer HEM;0XJ;4gl745-496

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomer-2.383eqm.1.A45-213
98.59